FHL3 and central nervous system cancer: However, it was confirmed that SOX4 can also promote tumor progression by interacting with the transcription factors Smad2/3 as well as dephosphorylating PPM1A and FHL3, which decreases the self-renewal capacity of glioma stem cells (34).